21 December 2023FeaturesBiotechnologySarah Speight

‘This was no David and Goliath story': Susman Godfrey on fighting off $86m claim for Globus Medical

Last week, Globus Medical defended an infringement claim worth $86 million in a patent dispute over spinal implants and related products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Pfizer strikes $10.5 billion oncology deal with Chinese biotech

4 June 2026 The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.

Biotechnology

Gilead to pay up to $5bn for antibody-drug conjugates push

8 April 2026 The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments.

Biotechnology

Closing the women's health gap offers ‘benefits for all’

7 April 2026 On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering.

More features

Hikma triumphs at SCOTUS in landmark skinny-label ruling

Pfizer strikes $10.5 billion oncology deal with Chinese biotech

Heated LNP litigation puts Moderna and Acuitas in the spotlight

J&J unit's valuable heart pump saved by 'rare' patent defence

Federal Circuit tosses $59m trade secrets judgment against EOFlow

Neal Gerber Eisenberg expands in Chicago with new litigator

Takeda’s China IP head: What pharma is still getting wrong

AI, anxiety, and antibodies: The issues dominating life sciences

‘This was no David and Goliath story': Susman Godfrey on fighting off $86m claim for Globus Medical

More on this story

Editor's picks

Editor's picks

More features